Methicillin-Resistant Staphylococcus Aureus (MRSA) - Articles and news items

M is for MRSA

Blog / 30 November 2016 / Niamh Louise Marriott, Digital Editor

M is for MRSA – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research…

MicuRx’S Phase III MRSA antibiotic trial to support Chinese NDA filing

Industry news / 20 October 2016 / Niamh Louise Marriott, Digital Content Producer

The recent $55M Series C financing will allow MicuRx to complete this Phase 3 study, and at a vital time with antibiotic resistance at an all time high…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+